Related Experiment Video
Updated: Feb 10, 2026

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation
Published on: July 17, 2019
Prevention and treatment of relapse after stem cell transplantation with immunotherapy
Nicola Gökbuget1, Jonathan Canaani2, Arnon Nagler2
1Department of Medicine II, Hematology/Oncology, University Hospital, Frankfurt, Germany.
Relapse has become the leading cause of treatment failure after stem cell transplantation. Besides cellular therapies and novel agents, immunotherapeutic strategies have entered clinical practice in order to reduce or prevent relapse. Here, we summarize the presentations on checkpoint inhibitors, vaccination strategies, and novel antibody therapies, which were presented and discussed at the third International Workshop on Biology, Prevention, and Treatment of Relapse after Stem Cell Transplantation.
Relapse has become the leading cause of treatment failure after stem cell transplantation. Besides cellular therapies and novel agents, immunotherapeutic strategies have entered clinical practice in order to reduce or prevent relapse. Here, we summarize the presentations on checkpoint inhibitors, vaccination strategies, and novel antibody therapies, which were presented and discussed at the third International Workshop on Biology, Prevention, and Treatment of Relapse after Stem Cell Transplantation.
Related Concept Videos
Induced Pluripotent Stem Cells
Tumor Immunotherapy
Adult Stem Cells
Embryonic Stem Cells
Cancer Prevention
Some...
Prevention of Further Absorption of Poison

